Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 172

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Breakthrough of solid tumor treatment: CAR-NK immunotherapy

Open access
Wang, Wenkang, Liu, Yang, He, Zhen, Li, Lifeng, Liu, Senbo, Jiang, Mingqiang, Zhao, Bing, Deng, Meng, Wang, Wendong, Mi, Xuefang, Sun, Zhenqiang, Ge, Xin · 2024 · Cell Death Discovery

Abstract

As the latest and most anticipated method of tumor immunotherapy, CAR-NK therapy has received increasing attention in recent years, and its safety and high efficiency have irreplaceable advantages over CAR-T. Current research focuses on the application of CAR-NK in hematological tumors, while there are fewer studies on solid tumor. This article reviews the process of constructing CAR-NK, the effects of hypoxia and metabolic factors, NK cell surface receptors, cytokines, and exosomes on the efficacy of CAR-NK in solid tumor, and the role of CAR-NK in various solid tumor. The mechanism of action and the research status of the potential of CAR-NK in the treatment of solid tumor in clinical practice, and put forward the advantages, limitations and future problems of CAR-NK in the treatment of solid tumor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41420-024-01815-9

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Metadata

Authors
Wang, W., Liu, Y., He, Z., Li, L., Liu, S., Jiang, M., Zhao, B., Deng, M., Wang, W., Mi, X., Sun, Z., & Ge, X.
Venue
Cell Death Discovery
Published
2024-01-20
Volume
10
Issue
1
Pages
40-40
ISSN
2058-7716 (ISSN-L)
OpenAlex
W4391046307
Cited by
172
References
21
FWCI
26.40
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Breakthrough of solid tumor treatment: CAR-NK immunotherapy. https://app.cochat.ai/papers/10.1038/s41420-024-01815-9
The paper
Wang, W., Liu, Y., He, Z., Li, L., Liu, S., Jiang, M., Zhao, B., Deng, M., Wang, W., Mi, X., Sun, Z., & Ge, X. (2024). Breakthrough of solid tumor treatment: CAR-NK immunotherapy. Cell Death Discovery. https://doi.org/10.1038/s41420-024-01815-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.